GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Redsense Medical AB (OTCPK:RDSNF) » Definitions » Total Assets

Redsense Medical AB (Redsense Medical AB) Total Assets : $2.18 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Redsense Medical AB Total Assets?

Redsense Medical AB's Total Assets for the quarter that ended in Mar. 2024 was $2.18 Mil.

Warning Sign:

If a company builds assets at 27.1% a year, faster than its revenue growth rate of 13.7% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, Redsense Medical AB's average Total Assets Growth Rate was -12.50% per year. During the past 3 years, the average Total Assets Growth Rate was 12.60% per year. During the past 5 years, the average Total Assets Growth Rate was 27.10% per year. During the past 10 years, the average Total Assets Growth Rate was 37.00% per year.

During the past 11 years, Redsense Medical AB's highest 3-Year average Total Assets Growth Rate was 59.50%. The lowest was 12.60%. And the median was 42.45%.

Total Assets is connected with ROA %. Redsense Medical AB's annualized ROA % for the quarter that ended in Mar. 2024 was -42.68%. Total Assets is also linked to Revenue through Asset Turnover. Redsense Medical AB's Asset Turnover for the quarter that ended in Mar. 2024 was 0.07.

Redsense Medical AB Total Assets Historical Data

The historical data trend for Redsense Medical AB's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Redsense Medical AB Total Assets Chart

Redsense Medical AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.01 9.41 4.76 2.96 2.58

Redsense Medical AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.06 2.68 2.60 2.58 2.18

Redsense Medical AB Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Redsense Medical AB's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=2.252+0.332
=2.58

Redsense Medical AB's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (Q: Mar. 2024 )+Total Liabilities (Q: Mar. 2024 )
=1.911+0.266
=2.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Redsense Medical AB  (OTCPK:RDSNF) Total Assets Explanation

Total Assets is connected with ROA %.

Redsense Medical AB's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %=Net Income (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=-1.016/( (2.584+2.177)/ 2 )
=-1.016/2.3805
=-42.68 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Redsense Medical AB's Asset Turnover for the quarter that ended in Mar. 2024 is

Asset Turnover
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=0.164/( (2.584+2.177)/ 2 )
=0.164/2.3805
=0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Redsense Medical AB Total Assets Related Terms

Thank you for viewing the detailed overview of Redsense Medical AB's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Redsense Medical AB (Redsense Medical AB) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Redsense Medical AB (OTCPK:RDSNF) » Definitions » Total Assets
Comparable Companies
NGM:MCLR XSAT:PHI OSTO:SCIB OSTO:DIGN OSTO:ACARIX OSTO:ARCOMA OSTO:ICO XSAT:VSD B OSTO:NOSA OSTO:SDOS ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
REDS:Sweden
Address
Box 7088, Halmstad, SWE, 300 07
Website
https://www.redsensemedical.com
Redsense Medical AB manufactures and sells blood loss detection devices in Sweden. The company has developed a monitoring system that can detect the first sign of a blood leak using patented fiber optic technology. The products of the company include Alarm Unit, Venous Needle Patch, Sensor Patch, and others.